We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $461M
1-Year Est. Return 33.26%
This Fund
S&P 500
This Quarter Est. Return
+9.59%
1 Year Est. Return
+33.26%
3 Year Est. Return
+35.29%
5 Year Est. Return
+56.36%
10 Year Est. Return
+229.32%
AUM
$461M
AUM Growth
+$37.5M
Cap. Flow
+$11.9M
Cap. Flow %
2.59%
Top 10 Hldgs %
48.35%
Holding
48
New
6
Increased
19
Reduced
11
Closed
8

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$16.1M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$10.7M
3
BSX icon
Boston Scientific
BSX
+$6.58M
4
IQV icon
IQVIA
IQV
+$6.58M
5
MDT icon
Medtronic
MDT
+$5.79M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$9.86M
2
GILD icon
Gilead Sciences
GILD
+$7.42M
3
AMGN icon
Amgen
AMGN
+$7.15M
4
LNTH icon
Lantheus
LNTH
+$7.08M
5
BIIB icon
Biogen
BIIB
+$6.87M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BMY icon
1
Bristol-Myers Squibb
BMY
$139B
$41.8M 9.08%
726,115
-101,786
-12% -$5.84M
MRK icon
2
Merck
MRK
$376B
$27.9M 6.05%
217,008
-43,332
-17% -$5.07M
MDT icon
3
Medtronic
MDT
$119B
$27.6M 5.98%
352,437
+71,755
+26% +$5.79M
PFE icon
4
Pfizer
PFE
$164B
$24.2M 5.25%
1,004,215
-87,170
-8% -$2.28M
INCY icon
5
Incyte
INCY
$25.9B
$19.4M 4.2%
170,753
-29,757
-15% -$2.95M
ELV icon
6
Elevance Health
ELV
$90B
$17.2M 3.73%
44,499
+537
+1% +$199K
BMRN icon
7
BioMarin Pharmaceuticals
BMRN
$12.9B
$16.9M 3.66%
294,918
+55,000
+23% +$3.01M
TMO icon
8
Thermo Fisher Scientific
TMO
$229B
$16.8M 3.65%
+33,584
New +$16.1M
CVS icon
9
CVS Health
CVS
$124B
$16.1M 3.49%
155,337
+20,000
+15% +$1.79M
IQV icon
10
IQVIA
IQV
$44.7B
$15.1M 3.27%
77,944
+37,714
+94% +$6.58M
IONS icon
11
Ionis Pharmaceuticals
IONS
$9.66B
$15M 3.26%
189,468
+20,000
+12% +$1.51M
BDX icon
12
Becton Dickinson
BDX
$51.1B
$14.1M 3.06%
93,168
+10,553
+13% +$1.58M
ABT icon
13
Abbott
ABT
$188B
$13.4M 2.9%
147,444
+59,912
+68% +$5.47M
GEHC icon
14
GE HealthCare
GEHC
$31.5B
$13.3M 2.89%
207,863
+81,445
+64% +$5.35M
ZBH icon
15
Zimmer Biomet
ZBH
$18.9B
$12.3M 2.66%
142,307
-13,528
-9% -$1.19M
BIIB icon
16
Biogen
BIIB
$33.2B
$11.7M 2.54%
54,163
-35,933
-40% -$6.87M
QGEN icon
17
Qiagen
QGEN
$9.06B
$11.2M 2.44%
287,640
+125,269
+77% +$4.65M
CNC icon
18
Centene
CNC
$33.6B
$10.4M 2.26%
162,405
– –
REGN icon
19
Regeneron Pharmaceuticals
REGN
$86.8B
$9.84M 2.13%
+15,780
New +$10.7M
BIO icon
20
Bio-Rad Laboratories Class A
BIO
$10.4B
$9.79M 2.12%
33,350
+9,600
+40% +$2.72M
CAH icon
21
Cardinal Health
CAH
$57.8B
$9.67M 2.1%
40,689
-14,208
-26% -$2.95M
AMGN icon
22
Amgen
AMGN
$240B
$9.52M 2.06%
26,281
-20,874
-44% -$7.15M
BRKR icon
23
Bruker
BRKR
$9.05B
$9.17M 1.99%
152,352
-101,658
-40% -$4.74M
AVTR icon
24
Avantor
AVTR
$10.3B
$8.97M 1.95%
906,088
+210,685
+30% +$1.81M
PTCT icon
25
PTC Therapeutics
PTCT
$5.96B
$8.16M 1.77%
100,000
+25,000
+33% +$1.81M
1
2

Similar funds

IAG
Investment Advisory Group Hanover, Massachusetts $461M AUM 22.74% 1-Year Est. Return
PAA
Peregrine Asset Advisers Portland, Oregon $461M AUM 43.48% 1-Year Est. Return
PC
Prevatt Capital Nassau, Bahamas $461M AUM 16.42% 1-Year Est. Return
HIP
Harrell Investment Partners Austin, Texas $461M AUM 31.07% 1-Year Est. Return
UCI
Uncommon Cents Investing Janesville, Wisconsin $461M AUM 32.58% 1-Year Est. Return
JC
Joho Capital New York $460M AUM 11.37% 1-Year Est. Return
BCM
Brightline Capital Management Miami, Florida $462M AUM 226.03% 1-Year Est. Return
GIM
Generali Investments Management Ljubljana, Slovenia $460M AUM 29.43% 1-Year Est. Return

Sector Gamma AS's Q2 2026 Portfolio in Review

As of Q2 2026, Sector Gamma AS held 48 positions worth $461M, up 8.9% from $423M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Sector Gamma AS's Q2 2026 filing shows 6 new, 19 increased, 11 reduced and 8 closed positions. Its largest new stake was Thermo Fisher Scientific: 33,584 shares worth $16.8M. The largest sale was UnitedHealth, an estimated $9.86M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Sector Gamma AS's largest Q2 2026 buy was Thermo Fisher Scientific: 33,584 shares worth $16.8M.
  • Sector Gamma AS added most to IQVIA in Q2 2026, an estimated $6.58M increase.
  • Sector Gamma AS's biggest Q2 2026 reduction was Amgen, cutting an estimated $7.15M.
  • Sector Gamma AS fully exited UnitedHealth in Q2 2026, selling an estimated $9.86M.
  • Sector Gamma AS's ten largest holdings make up 48% of its $461M portfolio in Q2 2026.
  • Sector Gamma AS opened 6 new positions and closed 8 in Q2 2026.
  • Sector Gamma AS's portfolio value rose 8.9% quarter-over-quarter to $461M.

Based on Sector Gamma AS's 13F filing for Q2 2026, filed 12 Aug 2026.